US Minimally-Invasive Cosmetic Procedures Market

ID: MRFR/MED/17448-HCR
100 Pages
Vikita Thakur
Last Updated: April 06, 2026
US Minimally Invasive Cosmetic Procedures Market Research Report By Products (Hair Removal Lasers, Botulinum Toxins, Microdermabrasion Products), By Procedures (Botulinum Toxins, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion), By Application (Acne, Trauma Scars, Hyperpigmentation, Adipose Tissue Regeneration) and By End User (Hospitals, Dermatology Clinics) - Growth & Industry Forecast 2025 To 2035
US Minimally-Invasive Cosmetic Procedures Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)8.01%
2024 Market Size$ 1,350 Million
2025 Market Size$ 1,458.14 Million
2035 Market Size$ 3,150 Million
Key Players
Allergan
Galderma
Revance Therapeutics
Medytox
Ipsen
Hugel
Trends
  • Technological Advancements
  • Personalization of Treatments
  • Regulatory Developments
Opportunities
  • Growing Aging Population
  • Increased Awareness and Acceptance
  • Advancements in Product Formulations
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Products (USD Million)
      1. 4.1.1 Hair Removal Lasers
      2. 4.1.2 Botulinum Toxins
      3. 4.1.3 Microdermabrasion Products
      4. 4.1.4 Others
    2. 4.2 Pharmaceutical, BY Procedures (USD Million)
      1. 4.2.1 Botulinum Toxins
      2. 4.2.2 Soft Tissue Fillers
      3. 4.2.3 Chemical Peel
      4. 4.2.4 Laser Hair Removal
      5. 4.2.5 Microdermabrasion
      6. 4.2.6 Others
    3. 4.3 Pharmaceutical, BY Application (USD Million)
      1. 4.3.1 Acne
      2. 4.3.2 Trauma Scars
      3. 4.3.3 Hyperpigmentation
      4. 4.3.4 Adipose Tissue Regeneration
      5. 4.3.5 Others
    4. 4.4 Pharmaceutical, BY End User (USD Million)
      1. 4.4.1 Hospitals
      2. 4.4.2 Dermatology Clinics
      3. 4.4.3 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Allergan (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Galderma (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Revance Therapeutics (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Medytox (KR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Ipsen (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Hugel (KR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Medytox (KR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sientra (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Medytox (KR)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PRODUCTS
    3. 6.3 US MARKET ANALYSIS BY PROCEDURES
    4. 6.4 US MARKET ANALYSIS BY APPLICATION
    5. 6.5 US MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY PRODUCTS, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY PRODUCTS, 2024 TO 2035 (USD Million)
    14. 6.14 PHARMACEUTICAL, BY PROCEDURES, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY PROCEDURES, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCTS, 2025-2035 (USD Million)
      2. 7.2.2 BY PROCEDURES, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Minimally-Invasive Cosmetic Procedures Market Segmentation

US Minimally-Invasive Cosmetic Procedures Market By Products (USD Million, 2025-2035)

  • Hair Removal Lasers
  • Botulinum Toxins
  • Microdermabrasion Products
  • Others

US Minimally-Invasive Cosmetic Procedures Market By Procedures (USD Million, 2025-2035)

  • Botulinum Toxins
  • Soft Tissue Fillers
  • Chemical Peel
  • Laser Hair Removal
  • Microdermabrasion
  • Others

US Minimally-Invasive Cosmetic Procedures Market By Application (USD Million, 2025-2035)

  • Acne
  • Trauma Scars
  • Hyperpigmentation
  • Adipose Tissue Regeneration
  • Others

US Minimally-Invasive Cosmetic Procedures Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Dermatology Clinics
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.